Viewing Study NCT06431893


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-09 @ 10:50 AM
Study NCT ID: NCT06431893
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-04-11
First Post: 2024-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)
Sponsor: Travere Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Homocystinuria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Classical homocystinuria View
None HCU View
None Cystathionine Beta Synthase Deficiency View